Dealmaking in Europe’s life sciences sector has been relatively muted in recent years, but the first half of 2025 has shown signs of strength as companies respond to the stark realities of an aging population -
Earlier this...more
7/23/2025
/ Acquisitions ,
Artificial Intelligence ,
EU ,
European Commission ,
Healthcare ,
Life Sciences ,
Mergers ,
Pharmaceutical Industry ,
Popular ,
Private Equity ,
Technology